BrightStar Announces Investment to Provide Technology for Better Management of Late-Stage Cancer

Technology Allows for Better Management of Late-Stage Cancer

MILWAUKEE, July 9, 2025 – BrightStar Wisconsin Foundation Inc. today announced that it has made an investment in AIQ Solutions, a Madison area company that provides powerful insights into the effectiveness that treatments are having on specific lesions for cancer patients.

AIQ’s software technology was born out of the research at the University of Wisconsin Carbone Cancer Center.  It takes images produced through the normal standard of care (CT or PET scans) and provides a view into the level of success of treatments that oncologists have not had before, allowing them to determine the best course of action for different parts of the body.  Doctors can now more rapidly review which therapies are having the best results for each individual.

“Almost all of us have a family member or friend impacted by metastatic cancer,” said Eric Horler, AIQ’s CEO.  “Oncologists are embracing this technology because it helps them optimize care and improve patient lives.”

The company is in the process of getting a new reimbursement billing code, but already has delivered almost 4,000 patient analysis spanning 10 hospital systems across the United States.  BrightStar joins a number of Wisconsin investment groups that co-invested in this round, including Rock River Capital, Capital Midwest, Wisconsin Investment Partners, Tundra Angels, Wisconsin Alumni Research Foundation, and NVNG Investment Advisors.

For more information about AIQ Solutions, please visit their website at www.aiq-solutions.com.